Oumar Diouf

3.2k total citations · 2 hit papers
9 papers, 1.3k citations indexed

About

Oumar Diouf is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Oumar Diouf has authored 9 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 2 papers in Molecular Biology. Recurrent topics in Oumar Diouf's work include CAR-T cell therapy research (5 papers), Viral-associated cancers and disorders (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Oumar Diouf is often cited by papers focused on CAR-T cell therapy research (5 papers), Viral-associated cancers and disorders (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Oumar Diouf collaborates with scholars based in United States, Germany and Belgium. Oumar Diouf's co-authors include Malcolm K. Brenner, Hao Liu, Helen E. Heslop, Cliona M. Rooney, Adrian P. Gee, Gianpietro Dotti, Barbara Savoldo, Enli Liu, Heidi V. Russell and Gary D. Myers and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Oumar Diouf

9 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

2011 882 citations Chrystal U. Louis, Barbara Savoldo et al. Blood profile →
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

2013 384 citations Catherine M. Bollard, Stephen Gottschalk et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Oumar Diouf

Since Specialization

Citations

This map shows the geographic impact of Oumar Diouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oumar Diouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oumar Diouf more than expected).

Fields of papers citing papers by Oumar Diouf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oumar Diouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oumar Diouf. The network helps show where Oumar Diouf may publish in the future.

Co-authorship network of co-authors of Oumar Diouf

This figure shows the co-authorship network connecting the top 25 collaborators of Oumar Diouf. A scholar is included among the top collaborators of Oumar Diouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oumar Diouf. Oumar Diouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic Stem Cell Transplant 2015 ·Biology of Blood and Marrow Transplantation ·Serena Perna, Stephen Gottschalk, Vicky Torrano, Oumar Diouf, (unknown), George Carrum, Carlos A. Ramos, Hao Liu, (unknown), Robert A. Krance, Kathryn Leung, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Catherine M. Bollard	2
2	Administration of LMP-specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive lymphoma post allogeneic stem cell transplant 2015 ·Cytotherapy ·(unknown), Serena Perna, Stephen Gottschalk, George Carrum, (unknown), Oumar Diouf, Meng‐Fen Wu, Robert A. Krance, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard	2
3	Autologous HER2 CMV bispecific CAR T cells for progressive glioblastoma: Results from a phase I clinical trial. 2015 ·Journal of Clinical Oncology ·Nabil Ahmed, Vita S. Brawley, Oumar Diouf, Alexia Ghazi, (unknown), Hao Liu, Cliona M. Rooney, Gianpietro Dotti, Adrian P. Gee, Robert G. Grossman, Yvonne Kew, David S. Baskin, Aidin Ashoori, Jonathan Zhang, John Hicks, Suzanne Z. Powell, Winfried S. Wels, Malcolm K. Brenner, Helen E. Heslop, Stephen Gottschalk	8
4	Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins breakdown → 2013 ·Journal of Clinical Oncology ·Catherine M. Bollard, Stephen Gottschalk, Vicky Torrano, Oumar Diouf, Stephanie Ku, Yasmin Hazrat, George Carrum, Carlos A. Ramos, Luis Fayad, Elizabeth J. Shpall, Barbara Pro, Hao Liu, Meng‐Fen Wu, Daniel Lee, Andrea M. Sheehan, Youli Zu, Adrian P. Gee, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney	384
5	Abstract 3500: T cells redirected against HER2 for the adoptive immunotherapy for HER2-positive osteosarcoma 2012 ·Cancer Research ·Nabil Ahmed, Vita S. Brawley, Oumar Diouf, Peter M. Anderson, John Hicks, Lisa Wang, Gianpietro Dotti, Winfried S. Wels, Hao Liu, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Stephen Gottschalk	7
6	Infusion of CD19-Directed and Multivirus Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation for B Cell Malignancies, 2011 ·Blood ·Carolina Colli Cruz, Kenneth Micklethwaite, Barbara Savoldo, Stephanie Ku, Robert A. Krance, Oumar Diouf, Rammurti T. Kamble, A. John Barrett, Elizabeth J. Shpall, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Catherine M. Bollard, Gianpietro Dotti	1
7	Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma breakdown → 2011 ·Blood ·Chrystal U. Louis, Barbara Savoldo, Gianpietro Dotti, Martin Pulé, Eric Yvon, Gary D. Myers, Claudia Rössig, Heidi V. Russell, Oumar Diouf, Enli Liu, Hao Liu, Meng-Fen Wu, Adrian P. Gee, Zhuyong Mei, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner	882
8	A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold 2002 ·Bioorganic & Medicinal Chemistry Letters ·Oumar Diouf, (unknown), (unknown), Michel Gelbcke, Patrice Talaga, B. Christophe, Michel Gillard, R. Massingham, Michel Guyaux	8
9	[Spinal concentrations of amoxicillin in purulent meningitis in children]. 1983 ·PubMed ·F. Denis, M. Cadoz, M Mounier, (unknown), Souleymane Mboup, Oumar Diouf, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact